NO20001415L - Farmasøytikum inneholdende vitamin-K-avhengige faktorer - Google Patents

Farmasøytikum inneholdende vitamin-K-avhengige faktorer

Info

Publication number
NO20001415L
NO20001415L NO20001415A NO20001415A NO20001415L NO 20001415 L NO20001415 L NO 20001415L NO 20001415 A NO20001415 A NO 20001415A NO 20001415 A NO20001415 A NO 20001415A NO 20001415 L NO20001415 L NO 20001415L
Authority
NO
Norway
Prior art keywords
containing vitamin
pharmaceuticals containing
dependent factors
dependent
factors
Prior art date
Application number
NO20001415A
Other languages
English (en)
Other versions
NO20001415D0 (no
Inventor
Yendra Linnau
Peter Turecek
Hans-Peter Schwarz
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of NO20001415D0 publication Critical patent/NO20001415D0/no
Publication of NO20001415L publication Critical patent/NO20001415L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Et farmasøytisk separert protrombinkomplekspreparat som inneholder minst 2 høytrensede vitamin K-avhengige enkelt- blodfaktorer.
NO20001415A 1997-09-19 2000-03-17 Farmasøytikum inneholdende vitamin-K-avhengige faktorer NO20001415L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0159197A AT409334B (de) 1997-09-19 1997-09-19 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren
PCT/AT1998/000224 WO1999015196A1 (de) 1997-09-19 1998-09-17 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren

Publications (2)

Publication Number Publication Date
NO20001415D0 NO20001415D0 (no) 2000-03-17
NO20001415L true NO20001415L (no) 2000-05-19

Family

ID=3516739

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001415A NO20001415L (no) 1997-09-19 2000-03-17 Farmasøytikum inneholdende vitamin-K-avhengige faktorer

Country Status (10)

Country Link
EP (1) EP1015020A1 (no)
JP (1) JP2001517636A (no)
AT (1) AT409334B (no)
AU (1) AU743102B2 (no)
BR (1) BR9812222A (no)
CA (1) CA2304396A1 (no)
HU (1) HUP0003681A1 (no)
NO (1) NO20001415L (no)
SK (1) SK4022000A3 (no)
WO (1) WO1999015196A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1458408B1 (en) 2001-12-21 2009-04-15 Novo Nordisk Health Care AG Liquid composition of factor vii polypeptides
WO2003075834A2 (en) * 2002-03-08 2003-09-18 Eli Lilly And Company Activated protein c formulations
EP1517698B2 (en) 2002-06-21 2017-12-06 Novo Nordisk Health Care AG STABILISED SOLID COMPOSITIONS OF FACTOR VIIa POLYPEPTIDES
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
WO2004103398A1 (en) 2003-05-23 2004-12-02 Novo Nordisk Health Care Ag Protein stabilization in solution
JP4658041B2 (ja) 2003-06-25 2011-03-23 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト Ｖｉｉ因子ポリペプチドの液体組成物
EP1656158B1 (en) 2003-08-14 2016-03-09 Novo Nordisk Health Care AG Liquid, aqueous pharmaceutical composition of factor vii polypeptides
EP2298287B1 (en) 2003-12-19 2018-04-11 Novo Nordisk Health Care AG Stabilised compositions of factor VII polypeptides
WO2006088741A2 (en) * 2005-02-16 2006-08-24 The Board Of Trustees Of The University Of Illinois Procoagulants based on metal-chelating lipids
EP1869082B1 (en) 2005-03-04 2011-04-13 The Board Of Trustees Of The University Of Illinois Coagulation and fibrinolytic cascades modulator
WO2009046194A2 (en) 2007-10-05 2009-04-09 The Board Of Trustees Of The University Of Illinois Fibrin sealant
WO2009061697A1 (en) 2007-11-09 2009-05-14 The Board Of Trustees Of The University Of Illinois Anticoagulant antagonist and hemophilia procoagulant
AU2011313505B2 (en) 2010-10-06 2015-09-17 Medimmune Limited Factor II and fibrinogen for treatment of haemostatic disorders
EP3579857B1 (en) * 2017-02-09 2022-04-06 CSL Behring GmbH A blood coagulation factor replacement product for use in the treatment or prophylaxis of bleedings

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729822D0 (en) * 1987-12-22 1988-02-03 Central Blood Lab Authority Chemical process
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
DE4430205A1 (de) * 1994-08-26 1996-02-29 Behringwerke Ag Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung
EP0796623B1 (de) * 1996-03-20 2005-05-25 Baxter Aktiengesellschaft Pharmazeutisches Präparat zur Behandlung von Blutgerinnungsstörungen

Also Published As

Publication number Publication date
BR9812222A (pt) 2000-07-18
SK4022000A3 (en) 2000-09-12
ATA159197A (de) 2001-12-15
JP2001517636A (ja) 2001-10-09
AU9244998A (en) 1999-04-12
AT409334B (de) 2002-07-25
HUP0003681A1 (hu) 2001-02-28
AU743102B2 (en) 2002-01-17
CA2304396A1 (en) 1999-04-01
WO1999015196A1 (de) 1999-04-01
EP1015020A1 (de) 2000-07-05
NO20001415D0 (no) 2000-03-17

Similar Documents

Publication Publication Date Title
CO5060503A1 (es) Formulaciones farmaceuticas
NO20001415L (no) Farmasøytikum inneholdende vitamin-K-avhengige faktorer
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
PT83872A (de) Arzneimittel
NO20002217D0 (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
DZ1966A1 (fr) Combinaison pharmaceutique nouvelle.
NO307459B1 (no) Piperazinderivater, samt farmasøytiske preparater inneholdende slike
FI853913A0 (fi) Farmaceutiska foereningar som antracyklinglykosider.
FI861532A0 (fi) Foerfarande foer att insamla uppgifter som en brand, branddetektor som utnyttjar detta foerfarande och brandalarmsystem som likasao utnyttjar detta foerfarande.
NO901657D0 (no) Fuktende baeremiddel for topisk administrering av vitamin a syre.
TR199700415A3 (tr) D3 vitamini analoglari.
YU52999A (sh) Kombinacija analgetika
ES2160410T3 (es) Preparados de complejos de protrombina inmunotolerantes.
NO982874D0 (no) Farmas°ytiske preparater med vitamin D-analoger
ES2193539T3 (es) Benzonaftiridinas.
AU8910698A (en) Alkali metal hybrid spin-exchange optical pumping
MX9603606A (es) N-metil-n-[(1s)-1-fenil-2-((3s)-3-hidroxipirrolidin-1-il) etil]-2,2-difenil-acetamida.
NO980923D0 (no) Optisk aktivt fenylpyrimidin-derivat som analgetisk middel
FI884545A0 (fi) Farmaceutisk komposition, som innehaoller avsvaellande piperidinoalkanolfoereningar.
IT1191255B (it) Composizione farmaceutiche a base di alcaloidi della segale cornuta 9,10-diidrogenati
FI883912A (fi) Centrifugalpumphjul och saett vid pumpning av en vaetska, som innehaoller gas, medelst en centrifugalpump.
UY26574A1 (es) " procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol".
DK1001942T3 (da) Polyhydroxybutylpyraziner, deres fremstilling samt medikamenter indeholdende disse forbindelser
LV10870A (lv) Jauni fosfolipidu atvasinajumi
FI894072A0 (fi) Polypeptider anvaendbara som vaccin.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application